Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Diabetes Right
  3. Trulicity (dulaglutide) injection Right
  4. Can Trulicity® (dulaglutide) be used while a patient is breastfeeding?
Search Trulicity (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Can Trulicity® (dulaglutide) be used while a patient is breastfeeding?

Eli Lilly and Company has no data for the use of dulaglutide in patients that are breastfeeding.

US_cFAQ_GLP125_USE_WHILE_BREASTFEEDING_LACTATION
US_cFAQ_GLP125_USE_WHILE_BREASTFEEDING_LACTATION
en-US

See important safety information, including boxed warning, in the attached prescribing information.

Use During Lactation

There are no data on

  • the presence of dulaglutide in human milk
  • the effects on the breastfed infant, or
  • the effects on milk production.1

The presence of dulaglutide in milk of treated lactating animals was not determined.1

The developmental and health benefits of breastfeeding should be considered along with

  • the mother’s clinical need for dulaglutide, and
  • any potential adverse events on the breastfed infant from dulaglutide or from the underlying maternal condition.1

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

Reference

1Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Date of Last Review: April 11, 2022

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly